Whaley, Jean M.

Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Meng, W., Ellsworth, B. A., Nirschl, A. A., McCann, P. J., Patel, M., Girotra, R. N., Wu, G., Sher, P. M., Morrison, E. P., Biller, S. A., et al. (2008) · Journal of Medicinal Chemistry

Diabetes Treatment and ManagementNatural Antidiabetic Agents Studies

Cited by 634

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans

List, J. F., & Whaley, J. M. (2011) · Kidney International

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 184